Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma With Failed Remission”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Ended earlyNCT03687125
What this trial is testing

Tinostamustine Conditioning and Autologous Stem Cell

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma With Failed Remission
Mundipharma-EDO GmbH 6
Not applicableActive Not RecruitingNCT05673083
What this trial is testing

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory+1 more
All4Cure 200
Early research (Phase 1)Study completedNCT03650491
What this trial is testing

FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma With Failed Remission
Fortis Therapeutics, Inc. 31
Early research (Phase 1)Active Not RecruitingNCT04184050
What this trial is testing

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

Who this might be right for
Multiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma of Bone+1 more
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Testing effectiveness (Phase 2)UnknownNCT04065308
What this trial is testing

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

Who this might be right for
Multiple Myeloma in RelapsePlasmacytomaDaratumumab
Seoul National University Hospital 33
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Testing effectiveness (Phase 2)Ended earlyNCT01174082
What this trial is testing

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 2